Ranjit S Bindra

21PUBLICATIONS
131CO-AUTHORS
Molecular targetsGene and molecular therapyImmunogenetics (incl. genetic immunology)Cancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jan 12, 2026
Targeted CRISPR knockout screening identifies known and novel chemogenomic interactions between DNA damaging agents and DNA repair genes.

Collin D Heer, James L Elia, Vijay Menon

|Jul 16, 2025
Systemic administration of an RNA binding and cell-penetrating antibody targets therapeutic RNA to multiple mouse models of cancer.

Elias Quijano, Diana Martinez-Saucedo, Zaira Ianniello

|Dec 10, 2024
The novel DNA cross-linking agent KL-50 is active against patient-derived models of new and recurrent post-temozolomide mismatch repair-deficient glioblastoma.

Matthew McCord, Thomas Sears, Wenxia Wang

|Jul 01, 2024
NAPRT Silencing in FH-Deficient Renal Cell Carcinoma Confers Therapeutic Vulnerabilities via NAD+ Depletion.

Katelyn J Noronha, Karlie N Lucas, Sateja Paradkar

|May 01, 2024
Exploiting Metabolic Defects in Glioma with Nanoparticle-Encapsulated NAMPT Inhibitors.

Matthew A Murray, Katelyn J Noronha, Yazhe Wang

|Nov 01, 2023
Intrathecal delivery of nanoparticle PARP inhibitor to the cerebrospinal fluid for the treatment of metastatic medulloblastoma.

Minsoo Khang, Ju Hyun Lee, Teresa Lee

Pageof 4

Frequent Collaborators

5 joint publications

W Mark Saltzman

4 joint publications

Ranjini K Sundaram

3 joint publications

Hee-Won Suh

2 joint publications

Patricia LoRusso